Cocaine-Induced Redoppuction of Glucose Utilization in Human Brain: A Study Using Positron Emission Tomography and [Fluorine 18]-Fluorodeoxyglucose

Archives of General Psychiatry

Volumn 47, Issue 6, 1990, Pages 567-574

  London, Edythe D ^a   Cascella, Nicola G ^a   Wong, Dean F ^a,b   Phillips, Robert L ^a   Dannals, Robert F ^a,b   Links, Jonathan M ^a,b   Herning, Ronald ^a   Grayson, Roger ^a   Jaffe, Jerome H ^a   Wagner, Henry N ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Department of Anesthesiology The Johns Hopkins Medical Institutions ^*

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; GLUCOSE;

ADULT; ARTICLE; BRAIN; CLINICAL ARTICLE; EUPHORIA; HUMAN; METABOLISM; NEOCORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; BRAIN; CEREBRAL CORTEX; COCAINE; DEOXYGLUCOSE; DOUBLE-BLIND METHOD; EUPHORIA; FLUDEOXYGLUCOSE F 18; GLUCOSE; HEART RATE; HUMAN; MALE; PLACEBOS; SUBSTANCE-RELATED DISORDERS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0025294009     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1990.01810180067010     Document Type: Article

References (49)

1. Grabowski J, ed. Cocaine: Pharmacology Effects and Treatment of Abuse. Washington, DC: National Institute on Drug Abuse; 1984. US Dept of Health and Human Services publication (ADM)84-1326.
2. Jaffe JH. Drug addiction and drug abuse. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds. The Pharmacological Basis of Therapeutics. New York, NY: Macmillan Publishing Co Inc; 1985:532-581.
3. Herning RI, Jones RT, Hooker WD, Mendelson J, Blackwell L. Cocaine increases EEG beta: a replication and extension of Hans Berger's historic experiments. Electroencephalogr Clin Neurophysiol. 1985;60:470-477.
4. Herning RI, Jones RT, Hooker WD, Tulunay FC. Information processing components of the auditory event related potential are reduced by cocaine. Psychopharmacology. 1985;87:178-185.
5. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987;237:1219-1223.
6. Ritchie JM, Greene NM. Local anesthetics. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds. The Pharmacological Basis of Therapeutics. New York, NY: Macmillan Publishing Co Inc; 1985:302-321.
7. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
8. McCulloch J. Mapping functional alterations in the CNS with [14C] deoxyglucose. In: Iversen LL, Iversen SD, Snyder SH, eds. Handbook of Psychopharmacology. New York, NY: Plenum Press; 1982;15:321-410.
9. London ED, Wilkerson G, Goldberg SR, Risner ME. Effects of 1-cocaine on local cerebral glucose utilization in the rat. Neurosci Lett. 1986;68:73-78.
10. Porrino LJ, Domer FR, Crane AM, Sokoloff L. Selective alterations in cerebral metabolism within the mesocortical dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacology. 1988;1:109-118.
11. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L. The [18F] fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44:127-137.
12. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-388.
13. Reivich M, Alavi A, Wolf A, Greenberg JH, Fowler J, Christman D, MacGregor R, Jones SC, London J, Shiue C, Yonekura Y. Use of 2-deoxy-D [1-11C] glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects. J Cereb Blood Flow Metab. 1982;2:307-319.
14. Theodore WH, DiChiro G, Margolin R, Porter RJ, Fishbein D, Brooks RA. Barbiturates reduce human cerebral glucose metabolism. Neurology. 1986;36:60-64.
15. Buchsbaum MS, Wu J, Haier R, Hazlett E, Ball R, Katz M, Sokolski K, Lagunas-Solar M, Langer D. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sci. 1987;40:2393-2400.
16. Foster NL, VanDerSpek AFL, Aldrich MS, Berent S, Hichwa RH, Sackellares JC, Gilman S, Agranoff BW. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. J Cereb Blood Flow Metab. 1987;7:415-420.
17. Wolkin A, Angrist B, Wolf A, Brodie J, Wolkin B, Jaeger J, Cancro R, Rotrosen J. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology. 1987;92:241-246.
18. London ED, Broussolle EPM, Links JM, Wong DF, Cascella NG, Dannals RF, Sano M, Herning R, Snyder FR, Rippetoe LR, Toung TJK, Jaffe JH, Wagner HN Jr. Morphine-induced metabolic changes in human brain: studies with positron emission tomography and [fluorine 18] fluorodeoxyglucose. Arch Gen Psychiatry. 1990;47:73-81.
19. Fanelli RJ, Szikszay M, Jasinski DR, London ED. Differential effects of mu & kappa opioid analgesics on cerebral glucose utilization in the rat. Brain Res. 1987;422:257-266.
20. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry. 1988;152:641-648.
21. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Barrio J, Rawson RA, Engel J, Guze BH, Selin C, Sumida R. Localization of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychiatry. 1988;49:23-26.
22. Annett M. A classification of hand preference by association analysis. Br J Psychol. 1970;61:303-321.
23. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389.
24. Shipley WC. Shipley Institute of Living Scale. Los Angeles, Calif: Western Psychological Services; 1986.
25. Grabowski J, Dworkin SI. Cocaine: an overview of current issues. Int J Addict. 1985;20:1065-1088.
26. Hamacher K, Coenen HH, Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
27. Jasper HH. The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol. 1958;10:370-375.
28. Sherer MA. Intravenous cocaine: psychiatric effects, biological mechanisms. Biol Psychiatry. 1988;24:865-885.
29. Muntaner C, Cascella NG, Kumor KM, Nagoshi C, Herning R, Jaffe J. Placebo responses to cocaine administration in humans: effects of prior administration and verbal instructions. Psychopharmacology. 1989;99:282-286.
30. Haertzen CA. An Overview of Addiction Research Center Inventory Scales (ARCI): An Appendix and Manual of Scales. Rockville, Md: National Institute on Drug Abuse; 1974:126. US Dept of Health, Education, and Welfare publication (ADM) 74-92.
31. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol. 1980;238:E69-E82.
32. Hutchins GD, Holden JE, Koeppe RA, Halama JR, Gatley SJ, Nickles RJ. Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab. 1984;4:35-40.
33. Hanaway J, Scott WR, Strother CM. Atlas of the Human Brain and the Orbit for Computed Tomography. St Louis, Mo; Warren H Green Inc; 1980.
34. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI. BMDP Statistical Software Manual. Los Angeles, Calif: University of California Press; 1988.
35. Sherer MA, Kumor KM, Jaffe JH. Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res. 1989;27:117-125.
36. Barrett JE. Behavioral history as a determinant of the effects of d-amphetamine on punished behavior. Science. 1977;198:67-69.
37. Barrett JE, Witkin JM. The role of behavioral and pharmacological history in determining the effects of abused drugs. In: Goldberg SR, Stolerman IP, eds. Behavioral Analysis of Drug Dependence. Orlando, Fla: Academic Press Inc; 1986:195-223.
38. Mazziotta JC, Phelps ME, Carson RE. Tomographic mapping of human cerebral metabolism: subcortical responses to auditory and visual stimulation. Neurology. 1984;34:825-828.
39. Horwitz B, Duara R, Rapoport SI. Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input. J Cereb Blood Flow Metab. 1984;4:484-499.
40. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res. 1987;407:294-306.
41. Mazziotta JC, Phelps ME, Halgren E. Local cerebral glucose metabolic response to audiovisual stimulation and deprivation: studies in human subjects with positron CT. Hum Neurobiol. 1983;2:11-23.
42. Scheel-Krüger J, Braestrup C, Nielson M, Golembiowska K, Mogilnicka E. Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. In: Ellinwood EH, Kilbey MM, eds. Cocaine and Other Stimulants. New York, NY: Plenum Press; 1977:373-408.
43. Ellinwood EH, Kilbey MM. Cocaine and Other Stimulants: Advances in Behavioral Biology. New York, NY: Plenum Press; 1977.
44. Risner ME, Jones BE. Intravenous self-administration of cocaine and norcocaine by dogs. Psychopharmacology. 1980;71:83-89.
45. Woolverton WL, Goldberg LI, Ginos JZ. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther. 1984;230:678-683.
46. Volkow ND, Brodie JD, Wolf AP, Angrist B, Russell J, Cancro R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry. 1986;49:1199-1202.
47. Goeders NE, Smith JE. Cortical dopaminergic involvement in cocaine reinforcement. Science. 1983;221:773-775.
48. Cannon WB. The James-Lange theory of emotions. Am J Psychol. 1927;39:106-124.
49. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci. 1987;10:197-245.